Use of weight-loss drugs soars among kids, young adults May 25, 2024 3:00 AM By Associated Press; Israel McKenzie is pictured in Chattanooga, Tenn., May 21, 2024.

In McKenzie's case, Jack prescribed the weight-loss drug Wegovy, which in late 2022 was approved for use in U.S. children over age 12. More than 6,000 kids in that age group received Wegovy in ...

The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.

At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job.

In McKenzie’s case, Jack prescribed the weight-loss drug Wegovy, which in late 2022 was approved for use in U.S. children over age 12. More than 6,000 kids in that age group received Wegovy in ...

Use of Wegovy and other weight-loss drugs soars among kids and young adults Israel McKenzie stands for a portrait in Chattanooga, Tenn., on Tuesday, May 21, 2024.

At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I was in a really dark place ...

The report shows that the number of 12- to 25-year-olds using any GLP-1 drug — including older medications first approved to treat diabetes in 2005 and for weight loss in 2014 — climbed from ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults. Use of weight-loss drugs soars among kids, young adults ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults. Use of weight-loss drugs soars among kids, young adults ...

At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job.“I was in a really dark place,&rd… ...